GoHealth Statistics
Total Valuation
GoHealth has a market cap or net worth of $32.59 million. The enterprise value is $673.15 million.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, before market open.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GoHealth has 28.85 million shares outstanding. The number of shares has increased by 29.66% in one year.
| Current Share Class | 16.23M |
| Shares Outstanding | 28.85M |
| Shares Change (YoY) | +29.66% |
| Shares Change (QoQ) | +13.95% |
| Owned by Insiders (%) | 6.04% |
| Owned by Institutions (%) | 37.43% |
| Float | 10.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.09 |
| Forward PS | 0.11 |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.02
| Current Ratio | 2.02 |
| Quick Ratio | 1.93 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.75 |
Financial Efficiency
Return on equity (ROE) is -219.72% and return on invested capital (ROIC) is -24.12%.
| Return on Equity (ROE) | -219.72% |
| Return on Assets (ROA) | -7.72% |
| Return on Invested Capital (ROIC) | -24.12% |
| Return on Capital Employed (ROCE) | -18.08% |
| Weighted Average Cost of Capital (WACC) | 10.39% |
| Revenue Per Employee | $425,700 |
| Profits Per Employee | -$307,118 |
| Employee Count | 850 |
| Asset Turnover | 0.29 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.34M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.94% in the last 52 weeks. The beta is 1.60, so GoHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | -88.94% |
| 50-Day Moving Average | 1.69 |
| 200-Day Moving Average | 3.62 |
| Relative Strength Index (RSI) | 33.33 |
| Average Volume (20 Days) | 87,332 |
Short Selling Information
The latest short interest is 533,301, so 1.85% of the outstanding shares have been sold short.
| Short Interest | 533,301 |
| Short Previous Month | 421,495 |
| Short % of Shares Out | 1.85% |
| Short % of Float | 5.26% |
| Short Ratio (days to cover) | 6.63 |
Income Statement
In the last 12 months, GoHealth had revenue of $361.85 million and -$261.05 million in losses. Loss per share was -$20.17.
| Revenue | 361.85M |
| Gross Profit | 265.72M |
| Operating Income | -152.94M |
| Pretax Income | -501.09M |
| Net Income | -261.05M |
| EBITDA | -79.83M |
| EBIT | -152.94M |
| Loss Per Share | -$20.17 |
Full Income StatementBalance Sheet
The company has $32.90 million in cash and $672.59 million in debt, with a net cash position of -$639.69 million or -$22.18 per share.
| Cash & Cash Equivalents | 32.90M |
| Total Debt | 672.59M |
| Net Cash | -639.69M |
| Net Cash Per Share | -$22.18 |
| Equity (Book Value) | -5.32M |
| Book Value Per Share | 2.34 |
| Working Capital | 144.29M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$121.95 million and capital expenditures -$8.25 million, giving a free cash flow of -$130.20 million.
| Operating Cash Flow | -121.95M |
| Capital Expenditures | -8.25M |
| Depreciation & Amortization | 73.11M |
| Net Borrowing | 135.62M |
| Free Cash Flow | -130.20M |
| FCF Per Share | -$4.51 |
Full Cash Flow StatementMargins
Gross margin is 73.43%, with operating and profit margins of -42.27% and -71.06%.
| Gross Margin | 73.43% |
| Operating Margin | -42.27% |
| Pretax Margin | -138.48% |
| Profit Margin | -71.06% |
| EBITDA Margin | -22.06% |
| EBIT Margin | -42.27% |
| FCF Margin | n/a |
Dividends & Yields
GoHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.66% |
| Shareholder Yield | -29.66% |
| Earnings Yield | -780.15% |
| FCF Yield | -389.09% |
Analyst Forecast
The average price target for GoHealth is $4.75, which is 320.47% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.75 |
| Price Target Difference | 320.47% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 18, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Nov 18, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
GoHealth has an Altman Z-Score of -0.88 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.88 |
| Piotroski F-Score | 2 |
